Epigenetic priming by Dot1l in lymphatic endothelial progenitors ensures normal lymphatic development and function
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoo, Hyunjin | - |
dc.contributor.author | Lee, Young Jae | - |
dc.contributor.author | Park, Chanhyeok | - |
dc.contributor.author | Son, Dabin | - |
dc.contributor.author | Choi, Dong Yoon | - |
dc.contributor.author | Park, Ji-Hyun | - |
dc.contributor.author | Choi, Hee-Jin | - |
dc.contributor.author | La, Hyun Woo | - |
dc.contributor.author | Choi, Yun-Jung | - |
dc.contributor.author | Moon, Eun-Hye | - |
dc.contributor.author | Saur, Dieter | - |
dc.contributor.author | Chung, Hyung Min | - |
dc.contributor.author | Song, Hyuk | - |
dc.contributor.author | Do, Jeong Tae | - |
dc.contributor.author | Jang, Hoon | - |
dc.contributor.author | Lee, Dong Ryul | - |
dc.contributor.author | Park, Chankyu | - |
dc.contributor.author | Lee, Ok-Hee | - |
dc.contributor.author | Cho, Ssang-Goo | - |
dc.contributor.author | Hong, Seok-Ho | - |
dc.contributor.author | Kong, Gu | - |
dc.contributor.author | Kim, Jin-Hoi | - |
dc.contributor.author | Choi, Youngsok | - |
dc.contributor.author | Hong, Kwonho | - |
dc.date.accessioned | 2022-07-08T16:45:54Z | - |
dc.date.available | 2022-07-08T16:45:54Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 2041-4889 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/146368 | - |
dc.description.abstract | Proper functioning of the lymphatic system is required for normal immune responses, fluid balance, and lipid reabsorption. Multiple regulatory mechanisms are employed to ensure the correct formation and function of lymphatic vessels; however, the epigenetic modulators and mechanisms involved in this process are poorly understood. Here, we assess the regulatory role of mouse Dot1l, a histone H3 lysine (K) 79 (H3K79) methyltransferase, in lymphatic formation. Genetic ablation of Dot1l in Tie2(+) endothelial cells (ECs), but not in Lyve1(+) or Prox1(+) lymphatic endothelial cells (LECs) or Vav1(+) definitive hematopoietic stem cells, leads to catastrophic lymphatic anomalies, including skin edema, blood–lymphatic mixing, and underdeveloped lymphatic valves and vessels in multiple organs. Remarkably, targeted Dot1l loss in Tie2(+) ECs leads to fully penetrant lymphatic aplasia, whereas Dot1l overexpression in the same cells results in partially hyperplastic lymphatics in the mesentery. Genetic studies reveal that Dot1l functions in c-Kit(+) hemogenic ECs during mesenteric lymphatic formation. Mechanistically, inactivation of Dot1l causes a reduction of both H3K79me2 levels and the expression of genes important for LEC development and function. Thus, our study establishes that Dot1l-mediated epigenetic priming and transcriptional regulation in LEC progenitors safeguard the proper lymphatic development and functioning of lymphatic vessels. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGERNATURE | - |
dc.title | Epigenetic priming by Dot1l in lymphatic endothelial progenitors ensures normal lymphatic development and function | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kong, Gu | - |
dc.identifier.doi | 10.1038/s41419-019-2201-1 | - |
dc.identifier.scopusid | 2-s2.0-85077603666 | - |
dc.identifier.wosid | 000511878700008 | - |
dc.identifier.bibliographicCitation | CELL DEATH & DISEASE, v.11, no.1, pp.1 - 16 | - |
dc.relation.isPartOf | CELL DEATH & DISEASE | - |
dc.citation.title | CELL DEATH & DISEASE | - |
dc.citation.volume | 11 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 16 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | COUP-TFII | - |
dc.subject.keywordPlus | LYMPHEDEMA-DISTICHIASIS | - |
dc.subject.keywordPlus | HEREDITARY LYMPHEDEMA | - |
dc.subject.keywordPlus | HEMOGENIC ENDOTHELIUM | - |
dc.subject.keywordPlus | TRANSCRIPTION FACTOR | - |
dc.subject.keywordPlus | H3K79 METHYLATION | - |
dc.subject.keywordPlus | VALVE DEVELOPMENT | - |
dc.subject.keywordPlus | LYMPHANGIOGENESIS | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | ORIGIN | - |
dc.identifier.url | https://www.nature.com/articles/s41419-019-2201-1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.